Curbing Cancer Drug Costs: Lartruvo Vial Sizes Designed To Reduce Waste
Lilly researchers used real-world data to identify a second vial size for Lartruvo that could reduce waste by nearly 87% compared to offering only a single large-size vial.
You may also be interested in...
Now-defunct AmerisourceBergen subsidiary inappropriately repackaged oncology support drugs like Neupogen and Procrit in pre-filled syringes, violating the law and prompting safety concerns, Department of Justice announced.
Accelerated filing was supported by trial of patients with 25 subtypes of soft tissue sarcoma and confirmatory study will span 50 kinds.
Amgen, Takeda and Merck push back against article’s conclusions on the waste generated by current vials for infused drugs.